BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24809224)

  • 1. Expression of three different ATP-binding cassette transporters and correlation to chemoresistance in acute myeloid leukemia.
    Palaiologou D; Panayiotidis P; Papanikolaou G; Georgiou G; Boutsikas G; Hatzinicolaou SL; Pangalis GA; Sakellaropoulos N; Vassilakopoulos TP; Angelopoulou MK
    Int J Lab Hematol; 2015 Feb; 37(1):e7-e10. PubMed ID: 24809224
    [No Abstract]   [Full Text] [Related]  

  • 2. ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients.
    Marzac C; Garrido E; Tang R; Fava F; Hirsch P; De Benedictis C; Corre E; Lapusan S; Lallemand JY; Marie JP; Jacquet E; Legrand O
    Haematologica; 2011 Sep; 96(9):1293-301. PubMed ID: 21606172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential topoisomerase targeting and analysis of mechanisms of resistance to topotecan in patients with acute myelogenous leukemia.
    Saraiya B; Gounder M; Dutta J; Saleem A; Collazo C; Zimmerman L; Nazar A; Gharibo M; Schaar D; Lin Y; Shih W; Aisner J; Strair RK; Rubin EH
    Anticancer Drugs; 2008 Apr; 19(4):411-20. PubMed ID: 18454051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients.
    Damiani D; Tiribelli M; Michelutti A; Geromin A; Cavallin M; Fabbro D; Pianta A; Malagola M; Damante G; Russo D; Fanin R
    Leuk Res; 2010 Jul; 34(7):942-5. PubMed ID: 20122734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry-based assessment of mitoxantrone efflux from leukemic blasts varies with response to induction chemotherapy in acute myeloid leukemia.
    Kim HP; Bernard L; Berkowitz J; Nitta J; Hogge DE
    Cytometry B Clin Cytom; 2012 Sep; 82(5):283-94. PubMed ID: 22508650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA let-7f is down-regulated in patients with refractory acute myeloid leukemia and is involved in chemotherapy resistance of adriamycin-resistant leukemic cells.
    Dai CW; Bai QW; Zhang GS; Cao YX; Shen JK; Pei MF; Yin CC
    Leuk Lymphoma; 2014 Jul; 55(7):1645-8. PubMed ID: 24067109
    [No Abstract]   [Full Text] [Related]  

  • 7. ATP-Binding Cassette transporters' gene expression in pediatric patients with acute leukemia; a comprehensive analysis of published reports through PubMed search engine.
    Mehrvar N; Akbari ME; Rezvany MR; Abolghasemi H; Saberynejad J; Mehrvar A; Faranoush M; Keramatinia AA; Shekarriz-Foumani R; Movafagh A
    Cell Mol Biol (Noisy-le-grand); 2019 Feb; 65(2):7-13. PubMed ID: 30860475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of Multiple ABC-Transporters is Strongly Associated with Treatment Response in Childhood Acute Myeloid Leukemia.
    Bartholomae S; Gruhn B; Debatin KM; Zimmermann M; Creutzig U; Reinhardt D; Steinbach D
    Pediatr Blood Cancer; 2016 Feb; 63(2):242-7. PubMed ID: 26512967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of chemoresistance with small interference RNA (siRNA) in etoposide resistant acute myeloid leukemia cells (HL-60).
    Kachalaki S; Baradaran B; Majidi J; Yousefi M; Shanehbandi D; Mohammadinejad S; Mansoori B
    Biomed Pharmacother; 2015 Oct; 75():100-4. PubMed ID: 26463638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.
    Benderra Z; Faussat AM; Sayada L; Perrot JY; Chaoui D; Marie JP; Legrand O
    Clin Cancer Res; 2004 Dec; 10(23):7896-902. PubMed ID: 15585622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP-binding casette transporter expression in acute myeloid leukemia: association with in vitro cytotoxicity and prognostic markers.
    Varatharajan S; Abraham A; Karathedath S; Ganesan S; Lakshmi KM; Arthur N; Srivastava VM; George B; Srivastava A; Mathews V; Balasubramanian P
    Pharmacogenomics; 2017 Feb; 18(3):235-244. PubMed ID: 28112576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia.
    Ho MM; Hogge DE; Ling V
    Exp Hematol; 2008 Apr; 36(4):433-42. PubMed ID: 18249061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCB6 RNA expression in leukemias--expression is low in acute promyelocytic leukemia and FLT3-ITD-positive acute myeloid leukemia.
    Abraham A; Karathedath S; Varatharajan S; Markose P; Chendamarai E; Jayavelu AK; George B; Srivastava A; Mathews V; Balasubramanian P
    Ann Hematol; 2014 Mar; 93(3):509-12. PubMed ID: 23793916
    [No Abstract]   [Full Text] [Related]  

  • 14. Letting microRNAs overcome resistance to chemotherapy in acute myeloid leukemia.
    Sakamoto KM
    Leuk Lymphoma; 2014 Jul; 55(7):1449-50. PubMed ID: 24206095
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypermethylation of CpG sites at the promoter region is associated with deregulation of mitochondrial ATPsyn-β and chemoresistance in acute myeloid leukemia.
    Yang J; Xiao X; Li R; Li Z; Deng M; Zhang G
    Cancer Biomark; 2016; 16(1):81-8. PubMed ID: 26835708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemia.
    Kühnl A; Kaiser M; Neumann M; Fransecky L; Heesch S; Radmacher M; Marcucci G; Bloomfield CD; Hofmann WK; Thiel E; Baldus CD
    Leuk Res; 2011 Dec; 35(12):1585-90. PubMed ID: 21899885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-arm deletions in chromosome 6 in acute myelogenous leukemia: update on two cases.
    Sundareshan TS; Lakshmi Devi V; Madhumathi DS; Appaji L; Girish MH; Prabhash K; Bapsy PP
    Cancer Genet Cytogenet; 2004 Oct; 154(1):93-5. PubMed ID: 15381383
    [No Abstract]   [Full Text] [Related]  

  • 18. A stress-responsive enhancer induces dynamic drug resistance in acute myeloid leukemia.
    Williams MS; Amaral FM; Simeoni F; Somervaille TC
    J Clin Invest; 2020 Mar; 130(3):1217-1232. PubMed ID: 31770110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The priming induction regimen of HAG as a low dose chemotherapy strategy in AML clonal evolution.
    Chen A; Yang J; Hu S; Wang QF
    Sci China Life Sci; 2015 Dec; 58(12):1302-5. PubMed ID: 26588914
    [No Abstract]   [Full Text] [Related]  

  • 20. Leukemia and ABC transporters.
    Fukuda Y; Lian S; Schuetz JD
    Adv Cancer Res; 2015; 125():171-96. PubMed ID: 25640270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.